Cargando…

Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance

BACKGROUND: The purpose of this study was to evaluate serum HE4 as a biomarker to detect recurrent disease during follow-up of patients with endometrial adenocarcinoma (EAC). METHODS: We performed a retrospective analysis of 98 EAC patients treated at Innsbruck Medical University, between 1999 and 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brennan, Donal J, Hackethal, Andreas, Mann, Kristy P, Mutz-Dehbalaie, Irene, Fiegl, Heidi, Marth, Christian, Obermair, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342867/ https://www.ncbi.nlm.nih.gov/pubmed/25655024 http://dx.doi.org/10.1186/s12885-015-1028-0

Ejemplares similares

Influence of Pregnancy-Related Conditions on Human Epididymis Protein 4 Serum Levels in Comparison to CA 125 – a Prospective Cohort Trial
por: Azim, Samira Abdel, et al.
Publicado: (2021)

Clinical Relevance of CDH1 and CDH13 DNA-Methylation in Serum of Cervical Cancer Patients
por: Abudukadeer, Abida, et al.
Publicado: (2012)

Recurrence of genitals warts in pre-HPV vaccine era after laser treatment
por: Widschwendter, Andreas, et al.
Publicado: (2019)

Surgical safety and personal costs in morbidly obese, multimorbid patients diagnosed with early-stage endometrial cancer having a hysterectomy
por: Obermair, Andreas, et al.
Publicado: (2016)

Evaluation of Vav3.1 as prognostic marker in endometrial cancer
por: Boesch, Maximilian, et al.
Publicado: (2018)

Evaluating L1CAM expression in human endometrial cancer using qRT-PCR
por: Notaro, Sara, et al.
Publicado: (2016)

Controversies in the Management of Endometrial Cancer
por: Hernandez, Enrique, et al.
Publicado: (2010)

Paucity of data evaluating patient centred outcomes following sentinel lymph node dissection in endometrial cancer: A systematic review
por: Obermair, Helena M., et al.
Publicado: (2021)

Can a symptom checklist improve the triage of patients following successful endometrial cancer treatment?
por: Peng, Yang, et al.
Publicado: (2020)

Fertility-sparing treatment in early endometrial cancer: current state and future strategies
por: Obermair, Andreas, et al.
Publicado: (2020)

HE4 as a Biomarker for Endometrial Cancer
por: Behrouzi, Roya, et al.
Publicado: (2021)

Patient experiences of conservative treatment for early stage endometrial cancer and endometrial hyperplasia with atypia using levonorgestrel intrauterine device: A qualitative study
por: O'Hara, Montana, et al.
Publicado: (2021)

Are endometrial cancer clinical practice management guidelines sufficiently consumer centric?
por: Obermair, Andreas, et al.
Publicado: (2022)

Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma
por: Quan, Quan, et al.
Publicado: (2021)

The cost-effectiveness of total laparoscopic hysterectomy compared to total abdominal hysterectomy for the treatment of early stage endometrial cancer
por: Graves, Nicholas, et al.
Publicado: (2013)

Differences in Epidural and Analgesic Use in Patients with Apparent Stage I Endometrial Cancer Treated by Open versus Laparoscopic Surgery: Results from the Randomised LACE Trial
por: Baker, Jannah, et al.
Publicado: (2013)

The value of serum HE4 and CA125 levels for monitoring the recurrence and risk stratification of endometrial endometrioid carcinoma
por: Gong, Sainan, et al.
Publicado: (2023)

The role of endometrial sampling for surveillance of recurrence in postmenopausal patients with medically inoperable stage I endometrial cancer
por: Carey-Love, Angelina, et al.
Publicado: (2020)

Endometrial cancer in a woman undergoing hysteroscopy for recurrent IVF failure
por: Gambadauro, Pietro, et al.
Publicado: (2017)

Expression of HE4 in Endometrial Cancer and Its Clinical Significance
por: Li, Xiao, et al.
Publicado: (2015)

Association of gamma-glutamyltransferase with severity of disease at diagnosis and prognosis of ovarian cancer
por: Grimm, C, et al.
Publicado: (2013)

Referral of Queensland women with endometrial cancer to genetic services
por: Tan, YY, et al.
Publicado: (2012)

Corrigendum to “Expression of HE4 in Endometrial Cancer and Its Clinical Significance”
por: Li, Xiao, et al.
Publicado: (2018)

Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers
por: Notaro, Sara, et al.
Publicado: (2016)

Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer
por: Leitner, Katharina, et al.
Publicado: (2020)

Endometrial cancer risk and survival by tumor MMR status
por: Nagle, Christina M., et al.
Publicado: (2018)

Identification and characterization of endometrial carcinoma with tumor markers HE4 and CA125 in serum and endometrial tissue samples
por: Cuesta-Guardiola, Tatiana, et al.
Publicado: (2021)

Beyond the Routine Influenza Surveillance
por: Choi, Sang-Ho
Publicado: (2016)

Value of serum miR-21, HE4 and CA125 in surveillance for postoperative recurrent or metastatic ovarian cancer
por: Gong, Zhenying, et al.
Publicado: (2022)

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients
por: Bignotti, E, et al.
Publicado: (2011)

Diagnostic value of serum HE4 in endometrial cancer: a meta-analysis
por: Bie, Yachun, et al.
Publicado: (2014)

Value of HE4 Combined with Cancer Antigen 125 in the Diagnosis of Endometrial Cancer
por: Dong, Chunhua, et al.
Publicado: (2017)

Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens
por: Schirmer, Uwe, et al.
Publicado: (2013)

Clinical impact of L1CAM expression measured on the transcriptome level in ovarian cancer
por: Azim, Samira Abdel, et al.
Publicado: (2016)

Correction to: Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens
por: Schirmer, Uwe, et al.
Publicado: (2018)

Rate of premalignant and malignant endometrial lesion in “low-risk” premenopausal women with abnormal uterine bleeding undergoing endometrial biopsy
por: Jha, Sangam, et al.
Publicado: (2021)

Recurrent Endometrial Cancer: Local and Systemic Treatment Options
por: Rütten, Heidi, et al.
Publicado: (2021)

Complementary and Alternative Medicine: Comparison of Current Knowledge, Attitudes and Interest among German Medical Students and Doctors
por: Münstedt, Karsten, et al.
Publicado: (2011)

HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell Lines
por: Li, Jinping, et al.
Publicado: (2013)

Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2aoc1kq1ls19hk5lutd05tg2fq